共 50 条
- [23] Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction AMERICAN HEART JOURNAL, 2016, 177 : 33 - 41
- [29] INS50589, a potent, selective, and reversible inhibitor of P2Y12 mediated platelet aggregation. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U120 - U120